http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103169849-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02898911a9c79256ee95420e73ffecfd |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8966 |
| filingDate | 2013-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0e8e6388a49e7a1c8b03388ded6c854 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e29b89a7206e97cc3a4cdc4f1fbf5832 |
| publicationDate | 2015-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103169849-B |
| titleOfInvention | Pharmaceutical composition for treating sore carbuncle swollen poison, and preparation method and use thereof |
| abstract | The invention provides a pharmaceutical composition for treating sore carbuncle swollen poison. The pharmaceutical composition is a preparation prepared from the following crude drugs by weight proportions of 10-15 parts of astragalus mongholicus, 12-18 parts of dandelion dried product or 25-40 parts of dandelion fresh product, 12-18 parts of Chinese violet dried product or 25-40 parts of Chinese violet fresh product, 7-13 parts of honeysuckle, 6-10 parts of fritillaria thun-bergli, 16-24 parts of spina gleditsiae, 7-13 parts of radix angelicae, 6-10 parts of radices sileris, 7-13 parts of frankincense, 7-13 parts of myrrh, 7-13 parts of Chinese angelica tail, 7-13 parts of root of common peony, 6-10 parts of stir-baked squama manitis, 7-13 parts of pericarpium citri reticulatae, 16-24 parts of radices trichosanthis and 6-10 parts of licorice section. The pharmaceutical composition provided by the invention can effectively remove the sore carbuncle swollen poison caused by heat toxin accumulation, stagnation of qi-blood, or heat toxin accumulation, qi-stagnation, blood stasis and phlegm coagulation, and provides a new choice for clinical medication. |
| priorityDate | 2013-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.